Oncology Startups 2017, is the first unique attempt to provide highly precise and updated information on newly established cancer drug developing companies and enables their early identification. The Report illuminates Top 500 cancer drug developers established during 2010-2016, and without any doubt is one of the world’s largest focused data coverage on Active Drug Developers working with numerous methodologies to target cancer. For Details https://omicsx.com/reports/cancer/oncology-startups-2017/

1. Oncology Startups 2017 5
OmicsX | Identify Partners - ONCOLOGY STARTUPS 2017
Foreword............................................................................................................................
List of Figures....................................................................................................................
List of Tables......................................................................................................................
List of Top 500 Oncology Startup Companies.................................................................
4
7
8
10
Section A : Oncology Startups 2017 - Top 500 Active Drug Developers' Summary
☐ Infographics - Quantitative Estimation of Oncology Startups present in U.S.A vs.
Europe vs. Asia vs.Canada vs. Rest of the World (established between
Jan 2010 to Sep 2016).
☐ Infographics - Distribution of Top 500 Oncology Startups, on the basis of Year of
Establishment.
To explore the emergence of Cancer Drug Discovery And Development.
☐ Infographics - Country-wise Distribution of Oncology Startups having Active
Cancer Drug Development Program in Europe and Asia Region.
To identify best and emerging countries, for promoting cancer startups.
☐ Infographics - State-wise Distribution of Oncology Startups having Active
Cancer Drug Development Program in U.S.A.
To explore the Top cancer startups supporting States in United States.
☐ Infographics - Divison of Top 500 Startups - ImmunoOncology Startup Companies
vs. Kinases Targeting vs. others.
To quantitatively explore the emerging areas of interest among startups.
☐ Infographics - Year wise and Region wise Distribution of ImmunoOncology Startups.
To explore emerging ImmunoOncology Supporting Region.
16
17
17
18
18
16
TABLE OF CONTENTS
15

2. OmicsX | Identify Partners - ONCOLOGY STARTUPS 2017
Oncology Startups 20176
☐ Intelligence - Rankwise List of Top 500 Oncology Startups.
Key Paramaters for Rank Score - Technology, Funding, Deals, Management & Pipeline.
☐ Intelligence - Top 25 Innovative Game Changer Oncology Startups.
Capable of changing tomorrow's Cancer Drug Discovery & Development.
☐ Intelligence - ImmunoOncology Focused Startups (225 Companies).
☐ Intelligence - Cancer Vaccine Focused Startups (49 Companies).
☐ Intelligence - Antibody Drug Conjugate Focused Startups (23 Companies).
☐ Intelligence - Oncolytic Virus & Gene Therapy Focused Startups (21 Companies).
☐ Intelligence - Stem Cells, CART & other Cell based Therapy Focused Startups.
(37 Companies)
19
25
Section B : Oncology Startups 2017 - Venture Funding & Big Pharma Partnering 33
☐ Infographics -Venture Funding in Oncology Startups.
Quantative Estmate of Funding in Series A vs Series B/C/D in last three years 2016, 2015 & 2014 in Startups.
☐ Intelligence - Oncology Startups SERIES A Venture Funding-2016 (uptill Sep.) (31 startups).
☐ Intelligence -Oncology Startups SERIES B/C Venture Funding-2016 (uptill Sep.)(17 startups).
☐ Intelligence - Oncology Startups SERIES A Venture Funding - 2015(38 startups).
☐ Intelligence - Oncology Startups SERIES B/C/D Venture Funding - 2015(13 startups).
☐ Intelligence - Oncology Startups SERIES A Venture Funding - 2014(20 startups).
☐ Intelligence - Oncology Startups SERIES B/C Venture Funding- 2014(8 startups).
☐ Intelligence - Key Venture Captial Investors in Oncology Startups and their Investment
Portfolio.
34
35
27
30
30
36
37
38
☐ Intelligence - Celgene Corporation - Strategic Deals & Investments in Oncology Startups.
☐ Intelligence - Janssen Biotech - Strategic Deals & Investments in Oncology Startups.
Investments through Johnson & Johnson Innovation - JJDC, Inc., also included.
☐ Intelligence - Roche & Genentech - Strategic Deals & Investments in Oncology Startups.
Investments through Roche Ventures also included.
☐ Intelligence - Novartis - Strategic Deals & Investments in Oncology Startups.
Investments through Novartis Ventures & Novartis Institute of Biomedical Research also included.
☐ Intelligence - Pfizer - Strategic Deals & Investments in Oncology Startups.
Investments through Pfizer Ventures also included.
☐ Intelligence - Sanofi - Strategic Deals & Investments in Oncology Startups.
Investments through Sanofi-Genzyme Bioventures also included.
Big Pharma Partnering, Deals & Investments in Startups -
Venture Funding Trends in Oncology Startups in Startups -
41
42
43
44
45
46
39
39
40
31
32

3. Oncology Startups 2017 7
OmicsX | Identify Partners - ONCOLOGY STARTUPS 2017
Appendix A: Country Wise List of 500 Oncology Startup Companies.................................
Appendix B: Complete 628 Molecules List, along with their Developer's Name..................
360
364
Section C : Oncology Startups 2017 -Company Profile (with Active Pipeline)
☐ A to Z Alphabetical Profiles of Active Oncology Startup Companies (500 Companies)
Individual company Pages includes: Company Profile, Company Rank, Key technology platform, Venture
Funding Rounds, Oncology centred Deals & Partnership, Collaborations and Business Insights.
Oncology Drug Pipeline –Drugs name, its targets, with details of its development for various indications for
cancer cure, FDA/EMEA Orphan drug status.
Management Profile –Address, Contact number, e-mail, Key Management / Decision Maker (CXOs) name
and designation, with individual Linked ID and contact emails.
53
☐ Intelligence - AstraZeneca - Strategic Deals & Investments in Oncology Startups.
Investments through MedImmune Ventures also included.
☐ Intelligence - Lilly - Strategic Deals & Investments in Oncology Startups.
Investments through Lilly Ventures & Lilly Asia Ventures also included.
☐ Intelligence - Bristol Myers Squib - Strategic Deals & Investments in Oncology Startups.
☐ Intelligence - Astellas - Strategic Deals & Investments in Oncology Startups.
Investments through Astellas Ventures also included.
☐ Intelligence - Merck & Company- Strategic Deals & Investments in Oncology Startups.
☐ Intelligence - Amgen - Strategic Deals & Investments in Oncology Startups.
Investments through Amgen Ventures also included.
47
48
49
50
51
52

4. OmicsX | Identify Partners - ONCOLOGY STARTUPS 2017
Oncology Startups 20178
Section A & B: Oncology Startups - Infographics 33
LIST OF FIGURES
Figure A.1 Qualitative Estimation of Top 500 Active Oncology Startups, established between 2010-2016;
present in U.S.A vs. Europe vs. Asia vs. Rest of the World.
Figure A.2 Bar Graph for year specific establishment of Top 500 Active Oncology Startups; during 2010 to
mid 2016.
Figure A.3 Individual Country specific Distribution of Oncology Startups (Drug Developer) in EuroAsia Region -
Europe (14 Countries) and in Asia (6 Countries).
Figure A.4 U.S State specific Distribution of Oncology Startups in U.S.A. (established from 2010 to mid 2016).
Figure A.5 Division of Top 500 Oncology Drug Development Startups -
Immuno-Oncology Startups vs. Kinases Targeting vs. Others.
Figure A.6 Year specific and Region specific Distribution of ImmunoOncology Startups.
Figure B.1 Total Venture Funding in Oncology Startups in 2014, 2015, 2016 (till Sep) in various A / B / C / D
series of funding rounds.
Figure B.2 Country specific companies securing venture funding in various A/B/C/D series of rounds, in
2016 (till Sep), 2015, & 2014.
16
16
17
17
18
18
34
34

5. Oncology Startups 2017 9
OmicsX | Identify Partners - ONCOLOGY STARTUPS 2017
SectionA&B:OncologyStartups- Intelligence
Table A.1 Top 500 Active Oncology Drug Developer Startups - Ranking
(based on Oncology Focused Technology, Funding, Deals, Pipeline and Key Management).
Table A.2 Top 30 Highly Innovative Startups capable of changing future of Oncology Drug Discovery &
Development.
Table A.3 Immuno-Oncology Focused StartUps, established between 2010 to mid 2016 (225 Companies).
Table A.4 Cancer Vaccine focused Oncology StartUps, established between 2010 to mid 2016 (49 Companies).
Table A.5 Antibody Drug Conjugate StartUps, established between 2010 to mid 2016 (23 Companies).
Table A.6 Oncolytic Virus & Gene Therapy StartUps, established between 2010 to mid 2016 (23 Companies).
Table A.7 Stem Cell, CART & other Cell based Therapy focused Startups (37 Companies).
Table B.1 Oncology Startups Venture Funding - 2016 (uptill Sep), Series A funding round.
Table B.2 Oncology Startups Venture Funding - 2016 (uptill Sep), Series B&C funding round.
Table B.3 Oncology Startups Venture Funding - 2015, Series A funding round.
Table B.4 Oncology Startups Venture Funding - 2015, Series B/C&D funding round.
Table B.5 Oncology Startups Venture Funding - 2014, Series A funding round.
Table B.6 Oncology Startups Venture Funding - 2014, Series B/C&D funding round.
Table B.7 Top 10 Venture Investors in Oncology Startups & Their Investment Portfolio.
Table B.8 Celgene Corporation Strategic Oncology Drug Development Deals with Oncology Startups.
Table B.9 Celgene Corporation Investment Portfolio in Oncology Drug Development Startups.
Table B.10 Janssen Biotech Strategic Oncology Drug Development Deals with Oncology Startups.
Table B.11 Janssen Biotech Investment Portfolio in Oncology Drug Development Startups.
Table B.12 Roche & Genentech Strategic Oncology Drug Development Deals with Oncology Startups.
Table B.13 Roche & Genentech Investment Portfolio in Oncology Drug Development Startups.
Table B.14 Novartis Strategic Oncology Drug Development Deals with Oncology Startups.
Table B.15 Novartis Venture Fund Investments in Oncology Drug Development Startups.
Table B.16 Novartis Institute of Biomedical Research Investments in Oncology Startups.
Table B.17 Pfizer Inc. Strategic Oncology Drug Development Deals with Oncology Startups.
Table B.18 Pfizer Investments in Oncology Drug Development Startups.
Table B.19 Sanofi SA Strategic Oncology Drug Development Deals with Oncology Startups.
Table B.20 Sanofi - Genzyme Bioventures Investment in Oncology Drug Development Startups.
Table B.21 Astrazeneca Strategic Oncology Drug Development Deals with Oncology Startups.
Table B.22 Astrazeneca Investments in Oncology Drug Development Startups.
Table B.23 Lilly Strategic Oncology Drug Development Deals with Oncology Startups.
Table B.24 Lilly Ventures Investments in Oncology Drug Development Startups.
Table B.25 Lilly Asia Ventures Investments in Oncology Drug Development Startups.
Table B.26 Bristol-Myers Squibb Strategic Oncology Drug Development Deals with Oncology Startups.
Table B.27 Astellas Strategic Oncology Drug Development Deals with Oncology Startups.
Table B.28 Astellas Ventures Investments in Oncology Drug Development Startups.
Table B.29 Merck & Company Strategic Oncology Drug Development Deals with Oncology Startups.
Table B.30 Amgen, Inc. Strategic Oncology Drug Development Deals with Oncology Startups.
Table B.31 Amgen Ventures Investments in Oncology Drug Development Startups.
39
LIST OF TABLES
19
25
30
27
30
31
32
35
36
37
38
39
39
40
41
41
42
42
43
43
44
44
44
45
45
46
46
47
47
48
48
48
49
50
50
51
52
52